Vor Biopharma (VOR) Other Non-Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Other Non-Current Assets data on file, last reported at $168000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 92.91% year-over-year to $168000.0 in Q1 2026; TTM through Mar 2026 was $168000.0, a 92.91% decrease from a year earlier, with the FY2025 full-year figure at $168000.0, down 93.04% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $168000.0, roughly flat from $168000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for VOR reached as high as $4.8 million in Q4 2023 and fell as low as $168000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $2.1 million across 5 years, with a median of $2.4 million in 2022.
• Across the five-year window, Other Non-Current Assets soared 99.42% in 2023 and slumped 93.04% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.4 million in 2022, then surged by 99.42% to $4.8 million in 2023, then tumbled by 49.85% to $2.4 million in 2024, then slumped by 93.04% to $168000.0 in 2025, then changed by 0.0% to $168000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $168000.0 in Q1 2026, $168000.0 in Q4 2025, and $269000.0 in Q3 2025.